期刊文献+

人pre-miR-145真核表达载体的构建及其对胃癌细胞游走、侵袭活性的影响 被引量:3

Construction of eukaryotic expression vector of human pre-miR-145 and its effects on the migration and invasion of gastric cancer in vitro
原文传递
导出
摘要 目的构建人微小RNAl45(miR-145)前体的真核表达载体,探讨其对胃癌细胞生物学行为的影响。方法根据人pre-miR-145序列,合成两条互补的寡核苷酸链,退火后连接人pPG-miR-EGFP载体,转化扩增后进行测序鉴定;重组质粒在阳离子脂质体Lipofectamine2000的介导下,瞬时转染人胃癌细胞株SGC-7901,实时定量聚合酶链反应(PCR)检测细胞中miR.145表达水平,黏附实验和Transwell小室实验检测癌细胞游走、侵袭能力。结果所构建的pPG—miRl45-EGFP载体中插入基因片段与设计序列完全匹配;重组质粒转染SGC.7901细胞后,miR-145表达分别上调20.45倍(P〈0.01),细胞黏附能力分别下降51.5%(P〈0.01),细胞侵袭能力分别下降30.4%(P〈0.01)。结论成功构建人pre—miR-145真核表达载体,转染胃癌细胞过表达后,能抑制癌细胞的游走和侵袭能力。 Objective To construct the eukaryotic expression vector of miR-145 and explore its effects on the biological behavior of gastric cancer. Methods According to the pre-miR-145 sequence, two complementary oligonucleotide strands were synthesized and inserted into pPG-miR-EGFP vector, which was validated by nucleic acid sequencing. Under the induction of Lipofectamine 2000, the recombinant was transfected into SGC-7901 cells. The expression level of miR-145 was detected by real-time reverse tran- scription-polymerase chain reaction (RT-PCR). The cell adhesion and transwell assays were applied for the detection of in vitro migration and invasion of cancer cells. Results Sequencing analysis confirmed the cor- rectness of the construction. Compared with negative control,the expression of miR-145 was upregulated by 20.45 times ( P 〈 0. 01 ). Meanwhile, the cellular adhesion was downregulated by 51.5 % ( P 〈 0. 01 ), and the invasive activity was downregulated by 30. 4% (P 〈 0. 01 ). Conclusion The expression vector of pre- miR-145 was successfully constructed,and induced the miR-145 overexpression in gastric cancer cells,resuiting in decrease of migration and invasion of cancer cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第4期571-573,共3页 Chinese Journal of Experimental Surgery
基金 基金项目:国家自然科学基金资助项目(30200284、30600278、30772359、81071997、81072073) 教育部“新世纪优秀人才支持计划”资助项目(NCET-06-0641) 教育部回国人员基金资助项目(2008889)
关键词 微小RNA145 胃癌 表达载体 microRNAI45 Gastric cancer Expression vector
  • 相关文献

参考文献9

  • 1Sachdeva M, Mo YY. miR-ld5-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res,2010,2 : 170-180.
  • 2Tazawa H, Kagawa S, Fujiwara T. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors. Expert Opin Biol T- her,2011,11 : 145-155.
  • 3Le XF, Merchant O, Bast RC, et al. The roles of micromas in the cancer invasion-metastasis cascade. Cancer Microenviron, 2010, 3 : 137- 147.
  • 4Farazi TA, Spitzer JI, Morozov P, et al. miRNAs in human cancer. J Pathol,2011,223 : 102-115.
  • 5Gregersen LH,Jacobsen AB, Frankel LB, et al. MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One,2010,5:8536.
  • 6Chen Z, Zeng H, Guo Y, et al. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting e-Mye. J Exp Clin Cancer Res, 2010,29 : 151.
  • 7Fuse M, Nohata N, Kojima S,et al. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCNI. Int J Onco1,2011,38 :1093-1101.
  • 8Takagi T, Iio A, Nakagawa Y, et al. Decreased expression of microR- NA-143 and -145 in human gastric cancers. Oncology, 2009,77 : 12- 21.
  • 9Scherr M, Venturini L, Eder M. Lentiviral vector-mediated expression of pre-miRNAs and antagomiRs. Methods Mot Biol, 2010,614 : 175- 185.

同被引文献46

  • 1伍晓汀.胃癌的诊治现状和展望[J].消化肿瘤杂志(电子版),2009,1(1):21-23. 被引量:1
  • 2王国民,武睿毅.我国前列腺癌实验研究的现状和展望[J].中华实验外科杂志,2005,22(9):1031-1034. 被引量:42
  • 3季加孚.我国胃癌防治研究三十年回顾[J].中国肿瘤临床,2013,40(22):1345-1351.
  • 4Lochhead PA,Gilley R,Cook SJ.ERK5 and its role in tumour development[J].Biochem Soc Trans,2012,40(1):251-256.
  • 5O' Donnell KA,Wentzel EA,Zeller KI,et al.c-Myc-regulated microRNAs modulate E2F1 expression[J].Nature,2005,435 (7043):839-843.
  • 6Ramsay AK,McCracken SR,Soofi M,et al.ERK5 signalling in prostate cancer promotes an invasive phenotype[J].Br J Cancer,2011,104(4):664-672.
  • 7Villadsen SB,Bramsen JB,Ostenfeld MS,et al.The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer[J].Br J Cancer,2012,106(2):366-374.
  • 8Yoshino H,Enokida H,Itesako T,et al.Tumor-suppressive microR-NA-143/145 cluster targets hexokinase-2 in renal cell carcinoma[J].Cancer Sci,2013,104 (12):1567-1574.
  • 9Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008 [ Jl. Int J Cancer,2010,127 (12) : 2893-2917.
  • 10Bartel DP. MiRNAs : genomics, biogenesis, mechanism and function [ J]. Cell ,2004,116 ( 2 ) :281-297.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部